序号 |
标题 |
次数 |
作者 |
发布时间 |
73171 |
Mal-PEG4-Val-Ala-PAB,可降解的ADC(抗体偶联药物)连接子 |
154 |
WYQ |
2024-12-19 |
73172 |
Mal-PEG1-Val-Cit-OH的介绍 |
124 |
zyl |
2024-12-19 |
73173 |
MC-vc-PAB-Monomethyl dolastatin10, ADC试剂 |
84 |
kx |
2024-12-19 |
73174 |
CAS: 1870916-87-2,Mal-Val-Ala-PAB,马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
91 |
WYQ |
2024-12-19 |
73175 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
85 |
zyl |
2024-12-19 |
73176 |
SuO-Val-Cit-PAB-MMAE, ADC试剂 |
75 |
kx |
2024-12-19 |
73177 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
88 |
zyl |
2024-12-19 |
73178 |
CAS: 2348405-93-4,DBCO-PEG4-Val-Ala-PAB-PNP |
64 |
WYQ |
2024-12-19 |
73179 |
CAS: 2348405-92-3,DBCO-PEG4-Val-Ala-PAB |
78 |
WYQ |
2024-12-19 |
73180 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
80 |
zyl |
2024-12-19 |
73181 |
Azido-PEG4-Val-Ala-PAB,分子式:C29H48N8O9 |
68 |
WYQ |
2024-12-19 |
73182 |
cas:2055896-86-9,MC-Val-Cit-PAB-tubulysin5a , ADC试剂 |
86 |
kx |
2024-12-19 |
73183 |
Azido-PEG8-Val-Cit-PAB-PNP |
65 |
zyl |
2024-12-19 |
73184 |
cas:2055896-83-6,MC-Val-Cit-PAB-carfilzomib , ADC试剂 |
108 |
kx |
2024-12-19 |
73185 |
MAL-di-EG-Val-Cit-PAB-MMAF, ADC试剂 |
78 |
kx |
2024-12-19 |
73186 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
87 |
zyl |
2024-12-19 |
73187 |
Hydrazone-doxorubicin, ADC试剂 |
156 |
kx |
2024-12-19 |
73188 |
DBCO-C4-Val-Cit-PABC-PNP |
67 |
zyl |
2024-12-19 |
73189 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
77 |
zyl |
2024-12-19 |
73190 |
cas:170908-81-3,DOTA-NHS ester ,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
69 |
kx |
2024-12-19 |
73191 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
77 |
zyl |
2024-12-19 |
73192 |
cas:2259318-50-6,MA-PEG4-VA-PBD , ADC试剂 |
91 |
kx |
2024-12-19 |
73193 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
61 |
WYQ |
2024-12-19 |
73194 |
CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE |
73 |
WYQ |
2024-12-19 |
73195 |
MC-vc-PAB-C6-a-amanitin, ADC试剂 |
66 |
kx |
2024-12-19 |
73196 |
cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 |
84 |
wyh |
2024-12-19 |
73197 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
84 |
zyl |
2024-12-19 |
73198 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,ADC定制 |
91 |
wyh |
2024-12-19 |
73199 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
113 |
zyl |
2024-12-19 |
73200 |
Gly3-vc-PAB-MMAE, ADC试剂 |
92 |
kx |
2024-12-19 |
73201 |
CAS: 1869126-64-6, Azido-PEG4-Val-Cit-PAB-MMAE |
73 |
WYQ |
2024-12-19 |
73202 |
cas:2353409-54-6 , Mal-amido-PEG8-Val-Gly,ADC定制 |
89 |
wyh |
2024-12-19 |
73203 |
Azido-PEG4-Val-Ala-PAB-PNP |
90 |
zyl |
2024-12-19 |
73204 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
75 |
h |
2024-12-19 |
73205 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid,ADC定制 |
83 |
wyh |
2024-12-19 |
73206 |
CAS: 1343476-44-7,Val-Ala-PAB-OH |
71 |
WYQ |
2024-12-19 |
73207 |
MC-PBD, ADC试剂 |
83 |
kx |
2024-12-19 |
73208 |
Mal-Val-Ala-PAB的介绍 |
82 |
zyl |
2024-12-19 |
73209 |
DOTA-K-A9 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)结合肽A9 |
72 |
h |
2024-12-19 |
73210 |
Azide-PEG3-Val-Cit-PAB-MMAF,叠氮-三聚乙二醇-Val-Cit-PAB-MMAF |
70 |
WYQ |
2024-12-19 |
73211 |
Arm-DOTA-B72.3 |
71 |
h |
2024-12-19 |
73212 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
87 |
zyl |
2024-12-19 |
73213 |
(Lys(DOTA)4)BVD15 DOTA偶联神经肽Y(NPY)类似物 |
120 |
h |
2024-12-19 |
73214 |
1801838-28-7,Mc-vc-PAB-SN38,化合物MC-VC-PAB-SN38 |
79 |
kx |
2024-12-19 |
73215 |
DOTA-PPI 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-官能化的聚(丙烯亚胺)(PPI)糖树枝状分子 |
78 |
h |
2024-12-19 |